Neuroprotective and anti-proliferative compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20060199835A1
SERIAL NO

10566752

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention features compounds of formula (I), (II) and (III), which are useful in the treatment of proliferative disorders characterized by loss of growth or cellular differentiation control including, but not limited to, cancer and inflammation. Formulas (I), (II), (III) have functional groups designated as A.sup.1, A.sup.2, B.sup.1, B.sup.2, X.sup.1--X.sup.9 and R.sup.1--R.sup.8 as defined further.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AEGERA THERAPEUTICS INCVERDUN QUEBEC H3E 1A8

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gillard, John W Baie D'Urfe, CA 43 358
Jaquith, James B Quebec, CA 22 100
Laurent, Alain Montreal, CA 59 675

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation